During the past decade, Borland-Groover Clinic Baptist conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Borland-Groover Clinic Baptist" are "Chronic Hepatitis C" (2 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "Borland-Groover Clinic Baptist" in a lesser frequency.

Most popular intervention types in "Borland-Groover Clinic Baptist" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "RBV" (3 trials), "PEG" (2 trials), "Sofosbuvir" (2 trials), "Placebo to match RBV" (1 trials) and "Placebo to match SOF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Borland-Groover Clinic Baptist" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Borland-Groover Clinic Baptist". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Borland-Groover Clinic Baptist, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Borland-Groover Clinic Baptist, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".